U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
ERLIZUMAB
INN   USAN   WHO-DD  
USAN   INN  
Official Name English
erlizumab [INN]
Preferred Name English
RHUMAB-CD18
Code English
Erlizumab [WHO-DD]
Common Name English
RHUMAB CD18
Code English
ERLIZUMAB [USAN]
Common Name English
Code System Code Type Description
CAS
211323-03-4
Created by admin on Wed Apr 02 09:05:08 GMT 2025 , Edited by admin on Wed Apr 02 09:05:08 GMT 2025
PRIMARY
INN
8076
Created by admin on Wed Apr 02 09:05:08 GMT 2025 , Edited by admin on Wed Apr 02 09:05:08 GMT 2025
PRIMARY
USAN
LL-50
Created by admin on Wed Apr 02 09:05:08 GMT 2025 , Edited by admin on Wed Apr 02 09:05:08 GMT 2025
PRIMARY
SMS_ID
100000175127
Created by admin on Wed Apr 02 09:05:08 GMT 2025 , Edited by admin on Wed Apr 02 09:05:08 GMT 2025
PRIMARY
ChEMBL
CHEMBL2109095
Created by admin on Wed Apr 02 09:05:08 GMT 2025 , Edited by admin on Wed Apr 02 09:05:08 GMT 2025
PRIMARY
FDA UNII
X77RS4CMJF
Created by admin on Wed Apr 02 09:05:08 GMT 2025 , Edited by admin on Wed Apr 02 09:05:08 GMT 2025
PRIMARY
WIKIPEDIA
Erlizumab
Created by admin on Wed Apr 02 09:05:08 GMT 2025 , Edited by admin on Wed Apr 02 09:05:08 GMT 2025
PRIMARY
NCI_THESAURUS
C169959
Created by admin on Wed Apr 02 09:05:08 GMT 2025 , Edited by admin on Wed Apr 02 09:05:08 GMT 2025
PRIMARY
ACTIVE MOIETY
ERLIZUMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966